Conference call to discuss RUBY and EdiTHAL clinical data will be held on December 11 at 1 pm. edit-301-program-update-dec-2023.open-exchange.net/registration’ target= ‘_blank’; rel=’nofollow’>Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EDIT:
- Editas Medicine price target lowered to $10 from $12 at Barclays
- Options Volatility and Implied Earnings Moves Today, November 03, 2023
- Editas Medicine Announces Third Quarter 2023 Results and Business Updates
- Editas Medicine reports Q3 EPS (55c), consensus (57c)
- Editas Medicine to present data from RUBY, EdiTHAL trials of EDIT-301